| Literature DB >> 24962675 |
Chibueze Ihekwereme1, Charles Esimone2, Di Shao3, Remigius U Agu4.
Abstract
There is need to develop reproducible methods and experimental models for screening mucosal irritation and toxicity for drugs and pharmaceutical excipients. The aim of this study was to validate Calu-3 cell line as a model for screening respiratory irritation and toxicity of drugs and excipients. Eighteen test compounds were selected according to their irritation potential and European Centre for the Validation of Alternative Methods (ECVAM) guidelines. Cell toxicity and irritation was determined using MTT assay. Data analysis and interpretation were done using modified ECVAM approach; where replicate values met acceptance criteria if percent relative standard deviation (RSD) of the raw data is <18%. Compounds with mean relative viability values of 50% and below were classified as irritant (I); those above 50% were non-irritant (NI). At low concentration (0.2% w/v) and 1 h incubation, the Calu-3 cell culture model accurately predicted the toxicity of most test compounds. The specificity of our proposed model (percentage of in vivo non-irritants correctly predicted), concordance (percentage of compounds correctly predicted) and sensitivity (percentage of in vivo irritants correctly predicted) at 0.2% w/v and 60 min exposure were 100%, 72%, and 44%, respectively. In conclusion, the Calu-3 cell line in conjunction with MTT assay appears to be a potentially useful tool for screening drugs and excipients for respiratory mucosa irritation and toxicity. However, as the data reported in this study were solely based on MTT assay, additional studies are needed using other toxicity-/irritation-indicating methods to confirm the observed trend.Entities:
Year: 2014 PMID: 24962675 PMCID: PMC4085599 DOI: 10.3390/pharmaceutics6020268
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Compounds used for toxicity studies.
| S/N | Chemical Name | Chemical Class | European Union Irritation Class | CAS Number | Log | ||
|---|---|---|---|---|---|---|---|
| Non-Irritating | R36 Irritating to Eye | R41 Risk of Serious Damage to Eye | Octanol–Water | ||||
| 1 | PEG 400 | Alcohol | √ | 25322-68-3 | −1.21 | ||
| 2 | 3-Methoxy-1,2-propanediol | Alcohol | √ | 623-39-2 | −1.20 | ||
| 3 | Glycerol | Alcohol | √ | 56-81-5 | −1.76 | ||
| 4 | PEG 600 | Alcohol | √ | 25322-68-3 | −1.21 | ||
| 5 | 2-Methyl-1-pentanol | Alcohol | √ | 105-30-6 | 1.75 | ||
| 6 | Anhydrous ethanol | Alcohol | √ | 64-17-5 | −0.30 | ||
| 7 | Cyclohexanol | Alcohol | √ | 108-93-0 | 1.23 | ||
| 8 | Tween 20 | Surfactant | √ | 9005-64-5 | 2.39 | ||
| 9 | Sodium dodecyl sulphate USP | Surfactant | √ | 151-21-3 | 1.60 | ||
| 10 | Triton X-100 | Surfactant | √ | 9002-93-1 | 4.15 | ||
| 11 | Cetylpyridinium bromide | Surfactant | √ | 140-72-7 | 1.83 | ||
| 12 | Toluene | Heterocyclic | √ | 108-88-3 | 2.73 | ||
| 13 | Imidazole | Heterocyclic | √ | 288-32-4 | −0.08 | ||
| 14 | Methyl isobutyl ketone | Ketone | √ | 108-10-1 | 1.31 | ||
| 15 | Acetone | Ketone | √ | 67-64-1 | −0.24 | ||
| 16 | Sodium hydroxide | Inorganic chemical | √ | 1310-73-2 | 0 | ||
| 17 | Sodium oxalate | Carboxylic acid salt | √ | 62-76-0 | −0.26 | ||
| 18 | 4-Fluoroaniline | Amine | √ | 371-40-4 | 1.15 | ||
* The Log p values were from [19,20].
Effect of test compounds on Calu-3 cells viability after incubation with 0.2% test solutions for 60 min.
| S/N | Test Compounds | Chemical Class | European Union Class | Calu-3 %Viability ± SD |
|---|---|---|---|---|
| 1 | PEG400 | Alcohol | NI | 91.5 ± 4.6 |
| 2 | 3-Methoxy-1,2-propanediol | Alcohol | NI | 92.6 ± 4.1 |
| 3 | Glycerol | Alcohol | NI | 85.6 ± 8.7 |
| 4 | PEG600 | Alcohol | NI | 85.9 ± 13.4 |
| 5 | 2-Methyl-1-pentanol | Alcohol | NI | 95.0 ± 13.1 |
| 6 | Anhydrous ethanol | Alcohol | NI | 99.1 ± 3.9 |
| 7 | Cyclohexanol | Alcohol | R41 | 89.9 ± 14.3 |
| 8 | Tween20 | Surfactant | NI | 57.1 ± 8.1 |
| 9 | Sodium dodecyl sulphate USP | Surfactant | R36 | 4.3 ± 0.1 |
| 10 | Triton X-100 | Surfactant | R36 | 3.5 ± 0.5 |
| 11 | Cetylpyridinium bromide | Surfactant | R41 | 8.1 ± 1.1 |
| 12 | Toluene | Heterocyclic | NI | 85.7 ± 13.0 |
| 13 | Imidazole | Heterocyclic | R41 | 106.9 ± 10.8 |
| 14 | Methyl isobutyl ketone | Ketone | NI | 73.2 ± 7.4 |
| 15 | Acetone | Ketone | R36 | 100.4 ± 13.7 |
| 16 | Sodium hydroxide | Inorganic chemical | R41 | 4.6 ± 0.4 |
| 17 | Sodium oxalate | Carboxylic acid salt | R41 | 65.4 ± 4.0 |
| 18 | 4-Fluoroaniline | Amine | R41 | 114.9 ± 5.9 |
European Union irritation classification: NI, non-irritant; R36, irritating to eye; R41, risk of serious damage to eyes.
Effect of test compounds on Calu-3 cells viability after incubation with 1.0% test solutions for 60 min.
| S/N | Chemical | Chemical Class | European Union Class | Calu-3 %Viability ± SD |
|---|---|---|---|---|
| 1 | PEG400 | Alcohol | NI | 92.2 ± 15.9 |
| 2 | 3-Methoxy-1,2-propanediol | Alcohol | NI | 90.7 ± 4.3 |
| 3 | Glycerol | Alcohol | NI | 86.5 ± 7.0 |
| 4 | PEG600 | Alcohol | NI | 81.7 ± 10.8 |
| 5 | 2-Methyl-1-pentanol | Alcohol | NI | 2.9 ± 0.2 |
| 6 | Anhydrous ethanol | Alcohol | NI | 90.3 ± 8.0 |
| 7 | Cyclohexanol | Alcohol | R41 | 78.7 ± 11.7 |
| 8 | Tween20 | Surfactant | NI | 43.9 ± 2.5 |
| 9 | Sodium dodecyl sulphate USP | Surfactant | R36 | 9.0 ± 0.1 |
| 10 | Triton X-100 | Surfactant | R36 | 4.5 ± 0.1 |
| 11 | Cetylpyridinium bromide | Surfactant | R41 | 5.4 ± 0.6 |
| 12 | Toluene | Heterocyclic | NI | 109.8 ± 6.6 |
| 13 | Imidazole | Heterocyclic | R41 | 95.4 ± 2.9 |
| 14 | Methyl isobutyl ketone | Ketone | NI | 90.3 ± 7.1 |
| 15 | Acetone | Ketone | R36 | 95.4 ± 16.5 |
| 16 | Sodium hydroxide | Inorganic chemical | R41 | 14.9 ± 1.2 |
| 17 | Sodium oxalate | Carboxylic acid salt | R41 | 64.5 ± 11.5 |
| 18 | 4-Fluoroaniline | Amine | R41 | 75.6 ± 10.9 |
European Union irritation classification: NI, non-irritants; R36, irritating to eye; R41, risk of serious damage to eyes.
Comparison of validation data, based on test compound concentration and 60 min exposure to Calu-3 cells.
| European Union Classification | Calu-3 Result | |||
|---|---|---|---|---|
| 0.2% Test Solutions | 1.0% Test Solutions | |||
| Irritants | Non-Irritants | Irritants | Non-Irritants | |
| Non-Irritants (9) | 0 | 9 | 2 | 7 |
| Irritants (9) | 4 | 5 | 4 | 5 |
Comparison of validation parameters (sensitivity, specificity, concordance) based on test compound concentration and 60 min exposure to Calu-3 cells. Comparison of results of Calu-3 cells treated with 0.2% and 1.0% test solutions for 60 min.
| Groups | Sensitivity * | Specificity ** | Concordance *** |
|---|---|---|---|
| 1.0% at 60 min treatment | 44% | 78% | 61% |
| 0.2% at 60 min treatment | 44% | 100% | 72% |
* Sensitivity, the percentage of irritants correctly predicted. This was obtained by dividing the number of correctly predicted irritants by the total number of irritants; ** Specificity, the percentage of non-irritants correctly predicted. This was obtained by dividing the number of correctly predicted non-irritants by the total number of non-irritants; *** Concordance, the percentage of chemicals correctly predicted. This was obtained by dividing the number of correctly predicted compounds by the total number of compounds.
Comparison of sensitivity, specificity and concordance of different assay methods used in prediction of mucosal toxicity.
| Methods | Sensitivity % | Specificity % | Concordance% | Source |
|---|---|---|---|---|
| BCOP | 75–84 | 79–81 | 79–81 | [ |
| SMI (mucus endpoint) | 75 | 100 | 68 | [ |
| Calu-3 cell model (0.2% at 60 min) | 44 | 100 | 72 |